连续皮下输注利多巴/糖多巴的现实世界经验:见解和建议
Thomas Koeglsperger1,2, Emir Berberovic3, Christian Dresel4
1Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany. thomas.koeglsperger@med.uni-muenchen.de.
Journal of neural transmission (Vienna, Austria : 1996)
|March 23, 2025
概括
持续的皮下利多巴/糖多巴输注 (CSFLI) 为晚期帕金森病 (PD) 提供了一种灵活的新选择. 现实世界的数据突出显示了患者选择,管理皮肤副作用,以及优化CSFLI治疗的口服药物.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 医疗器械 医疗器械
背景情况:
- 先进的帕金森病 (PD) 管理包括解决运动波动和运动障碍.
- 已建立的疗法包括持续的阿波莫尔芬输液 (CSAI),莱沃多巴-卡比多巴肠凝 (LCIG),莱沃多巴-卡比多巴恩塔卡肠凝 (LECIG) 和深度大脑刺激 (DBS).
- 持续的皮下利多巴/糖多巴输注 (CSFLI) 是最近的治疗进步.
研究的目的:
- 提供从一年的实践经验与CSFLI在高级PD.提供见解.
- 为临床医生指导,为个别患者选择最合适的设备辅助疗法.
- 讨论CSFLI的优势,局限性和管理策略.
主要方法:
- 一年来对CSFLI的实际临床经验的分析.
- 对CSFLI与其他设备辅助疗法进行比较的考虑,用于患者选择.
- 评估CSFLI的疗效,灵活性,易用性和副作用概况.
- 制定预防和管理CSFLI相关不良事件的建议.
- 优化与CSFLI同时使用口服药物的策略.
主要成果:
- CSFLI提供了一种新的选择,具有经过证明的灵活性和易用性.
- 皮肤相关问题被确定为需要主动管理的首要限制.
- 为患者选择提供了指导,在特定的晚期PD病例中偏爱CSFLI.
- 概述了平衡疗法与口服药物的策略.
结论:
- CSFLI是治疗晚期帕金森病的宝贵补充.
- 仔细的患者选择和对副作用的勤奋管理对于成功实施CSFLI至关重要.
- 优化CSFLI与口服药物的组合可以提高整体治疗疗效.
相关概念视频
01:29Drug Delivery: Parenteral Route
355
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
355
01:09One-Compartment Model: IV Infusion
138
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
138